个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Wang, Yu[1] ; Zhang, Jianmin[2] ; Li, Wenbin[3] ; Jiang, Taipeng[4] ; Qi, Songtao[5] ; Chen, Zhongping[6] ; Kang, Jingbo[7] ; Huo, Lei[8] ; Wang, Yunjie[9] ; Zhuge, Qichuan[10] ; Gao, Guodong[11] ; Wu, Yuping[12] ; Feng, Hua[13] ; Zhao, Gang[14] ; Yang, Xiaopeng[15] ; Zhao, Hui[16] ; Wang, Yirong[17] ; Yang, Hui[18] ; Kang, Dezhi[19] ; Su, Jun[20] ; Li, Liang[21] ; Jiang, Chuanlu[22] ; Li, Gang[23] ; Qiu, Yongming[24] ; Wang, Weimin[25] ; Wang, Handong[26] ; Xu, Zaihua[27] ; Zhang, Liwei[3] ; Wang, Renzhi[1] ;
机构： [1]Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 100010, China [2]Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, 310009, China [3]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 100070, China [4]Department of Neurosurgery, Shenzhen Second People’s Hospital, 518035, China [5]Department of Neurosurgery, Nanfang Hospital Southern Medical University, 510515, China [6]Department of Neurosurgery, Sun Yat-Sen University Cancer Center, 510060, China [7]Tumor Diagnosis & Treatment Center, The Sixth Medical Center of PLA General Hospital, 100048, China [8]Department of Neurosurgery, Xiangya Hospital Central South University, 410008, China [9]Department of Neurosurgery, The First Hospital of China Medical University, 110001, China [10]Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, 325000, China [11]Department of Neurosurgery, The Fourth Military University Tangdu Hospital, 710032, China [12]Department of Craniobasal Neurology, Sichuan Cancer Hospital & Institute, The Affiliated Cancer Hospital, School of Medicine,UESTC, 610041, China [13]Department of Neurosurgery, Southwest Hospital, The First Affiliated Hospital of Army Medical University, 400038, China [14]Department of Neurosurgery, The First Bethune Hospital of Jilin University, 130021, China [15]Department of Neurosurgery, People’s Hospital of Xinjiang Uygur Autonomous Region, 830001, China [16]Department of Radiotherapy, People’s Hospital of Xinjiang Uygur Autonomous Region, 830001, China [17]Department of Neurosurgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310016, China [18]Department of Neurosurgery, Xinqiao Hospital of Army Medical University, 400037, China [19]Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, 350005, China [20]Department of Neurosurgery, Tumor Hospital of Harbin Medical University, 150081, China [21]Department of Neurosurgery, Peking University First Hospital, 100034, China [22]Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, 150001, China [23]Department of Neurosurgery, Qilu Hospital of Shandong University, 250012, China [24]Department of Neurosurgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200127, China [25]Department of Neurosurgery, General Hospital of Southern Theatre Command, 510010, China [26]Department of Neurosurgery, General Hospital of Eastern Theatre Command, 210002, China [27]Department of Neurosurgery, General Hospital of Northern Theatre Command, 110840, China
出处：
DOI： 10.2217/fon-2021-0435
ISSN：

关键词： adjuvant chemotherapy conformity glioblastoma multiforme glioma Stupp regimen temozolomide

摘要：
Aims: To determine how consistently Chinese glioblastoma multiforme (GBM) patients were treated according to the Stupp regimen. Patients and methods: The proportion of treatments conforming to the Stupp regimen and reasons for nonconformity were evaluated in 202 newly diagnosed GBM patients. Results: Only 15.8% of GBM patients received treatments compliant with the Stupp regimen. The main deviations were temozolomide dosages >75 mg/m(2) (58/120; 48.3%) and treatment durations <42 days (84/120; 70.0%) in the concomitant phase and temozolomide dosages <150 mg/m(2) (89/101; 88.1%) in the maintenance phase. Median overall survival (27.09 vs 18.21 months) and progression-free survival (14.27 vs 12.10 months) were longer in patients who received Stupp regimen-compliant treatments. Conclusion: Increased conformity to the Stupp regimen is needed for GBM patients in China. Lay abstract In 2005 the European Organization for Research and Treatment of Cancer 26981 study led to US FDA approval for the use of temozolomide in combination with radiotherapy to treat glioblastoma multiforme (GBM). The Stupp regimen consists of fractionated focal irradiation in daily fractions of 2 Gy given 5 days/week for 6 weeks (a total of 60 Gy), plus concomitant daily temozolomide (75 mg/m(2)/day, 7 days/week from the first to the last day of radiotherapy), followed by six cycles of adjuvant temozolomide (150-200 mg/m(2)/day for 5 days during each 28-day cycle). In 2012 the Chinese guidelines for the diagnosis and treatment of glioma of the CNS recommended the Stupp regimen as first-line therapy for newly diagnosed GBM. In the present study, compliance of GBM treatments with the Stupp regimen in 28 Chinese centers from 2012-2016 was evaluated. Only 15.8% of GBM patients received treatments compliant with the Stupp regimen. The main deviations related to temozolomide dosages and treatment durations in the concomitant and maintenance phases. Median overall survival (27.09 vs 18.21 months) and progression-free survival (14.27 vs 12.10 months) were longer in patients who received Stupp regimen-compliant treatments.

基金：
MSD China
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2023]版：
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区：
出版当年[2021]版：
Q3 ONCOLOGY
最新[2023]版：
Q2 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 100010, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Wang Yu,Zhang Jianmin,Li Wenbin,et al.Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China[J].FUTURE ONCOLOGY.2021,17(33):4571-4582.doi:10.2217/fon-2021-0435.
APA：
Wang, Yu,Zhang, Jianmin,Li, Wenbin,Jiang, Taipeng,Qi, Songtao...&Wang, Renzhi.(2021).Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.FUTURE ONCOLOGY,17,(33)
MLA：
Wang, Yu,et al."Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China".FUTURE ONCOLOGY 17..33(2021):4571-4582

相关文献

[1]Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme [2]Single-cell transcriptomic analysis identifies downregulated phosphodiesterase 8B as a novel oncogene in IDH-mutant glioma [3]左乙拉西坦联合替莫唑胺作用于胶质瘤细胞的体外研究 [4]Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development [5]INTERFERON-ALPHA ENHANCES TEMOZOLOMIDE ANTI-GLIOMA EFFICACY: FROM BENCH TO BEDSIDE [6]Identifying A Radiomics Imaging Signature for Prediction of Overall Survival in Glioblastoma Multiforme [7]Automatic extraction of MRI radiomics features in glioblastoma multiforme: A reproducibility evaluation [8]ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma. [9]Automatic Extraction of MRI Radiomics Features in Glioblastoma Multiforme: A Reproducibility Evaluation [10]The comparison genomics analysis with glioblastoma multiforme (GBM) cells under 3D and 2D cell culture conditions.

资源点击量：43377 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号